Your browser doesn't support javascript.
loading
Morphea Associated with Adalimumab Treatment: The Role of TNF-α in Inhibition of Fibrosis.
Gracia-Cazaña, Tamara; Fuentelsaz, Victoria; Navarro-Bielsa, Alba; Giner-Serret, Emilio; García-Latasa, Francisco Javier.
Afiliación
  • Gracia-Cazaña T; Department of Dermatology, Hospital Miguel Servet, Zaragoza, Spain; tamgracaz@gmail.com.
  • Fuentelsaz V; Dermatology Service, Hospital Royo Villanova, Zaragoza, Spain.
  • Navarro-Bielsa A; Department of Dermatology, Hospital Miguel Servet, Zaragoza, Spain.
  • Giner-Serret E; Reumatology Service, Hospital Royo Villanova, Zaragoza, Spain.
  • García-Latasa FJ; Dermatology Service, Hospital Royo Villanova, Zaragoza, Spain.
Skinmed ; 22(4): 296-297, 2024.
Article en En | MEDLINE | ID: mdl-39285573
ABSTRACT
Anti-tumor necrosis factor alpha (anti-TNF-α) comprises a group of drugs that inhibit the action of cytokine TNF-α, and are used to treat diseases mainly caused by this cytokine. An increase in cutaneous adverse events has been observed with similar anti-TNF biologic treatments frequently used in clinical practice.
Asunto(s)
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Localizada / Factor de Necrosis Tumoral alfa / Adalimumab Límite: Humans Idioma: En Revista: Skinmed Asunto de la revista: DERMATOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Localizada / Factor de Necrosis Tumoral alfa / Adalimumab Límite: Humans Idioma: En Revista: Skinmed Asunto de la revista: DERMATOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos